Evidence map›Paper›PMID 38799301›Full record

ArticleACS omega2024

α-Hydrazino Acid Insertion Governs Peptide Organization in Solution by Local Structure Ordering.

Luka Kavčič, Gregor Ilc, Baifan Wang, Kristina Vlahoviček-Kahlina, Ivanka Jerić, Janez Plavec

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Luka KavčičSlovenian NMR Centre, National Institute of Chemistry, Ljubljana 1000, Slovenia.
Gregor IlcSlovenian NMR Centre, National Institute of Chemistry, Ljubljana 1000, Slovenia.
Baifan WangSlovenian NMR Centre, National Institute of Chemistry, Ljubljana 1000, Slovenia.
Kristina Vlahoviček-KahlinaDivision of Organic Chemistry and Biochemistry, Rudjer Bošković Institute, Zagreb 10000, Croatia.
Ivanka JerićDivision of Organic Chemistry and Biochemistry, Rudjer Bošković Institute, Zagreb 10000, Croatia.ORCID https://orcid.org/0000-0001-9245-3530
Janez PlavecSlovenian NMR Centre, National Institute of Chemistry, Ljubljana 1000, Slovenia.ORCID https://orcid.org/0000-0003-1570-8602

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, we have applied the concept of α-hydrazino acid insertion in a peptide sequence as a means of structurally organizing a potential protein-protein interactions (PPI) inhibitor. Hydrazino peptides characterized by the incorporation of an α-hydrazino acid at specific positions introduce an additional nitrogen atom into their backbone. This modification leads to a change in the electrostatic properties of the peptide and induces the restructuring of its hydrogen bonding network, resulting in conformational changes toward more stable structural motifs. Despite the successful use of synthetic hydrazino oligomers in binding to nucleic acids, the structural changes due to the incorporation of α-hydrazino acid into short natural peptides in solution are still poorly understood. Based on NMR data, we report structural models of p53-derived hydrazino peptides with elements of localized peptide structuring in the form of an α-, β-, or γ-turn as a result of hydrazino modification in the peptide backbone. The modifications could potentially lead to the preorganization of a helical secondary peptide structure in a solution that is favorable for binding to a biological receptor. Spectroscopically, we observed that the ensemble averaged rapidly interconverting conformations, including isomerization of the E-Z hydrazide bond. This further increases the adaptability by expanding the conformational space of hydrazine peptides as potential protein-protein interaction antagonists.

Identifiers

PMID38799301
PMCPMC11112695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.